Sponsored Content | Case Study | Radiation Oncology | September 04, 2019

First Clinical Experience With the RayCare OIS

Iridium Cancer Network

Iridium Cancer Network

Piet Dirix

Piet Dirix

Iridium Cancer Network consists of all seven hospitals in the Antwerp region, closely collaborating regarding radiation oncology. The network acts as a single radiation therapy department, making it the largest in Belgium with its annual 5,300 patients. Iridium was first to use the RayCare* oncology information system (OIS) clinically, only two months after it was released from RaySearch.

Iridium Cancer Network became a RaySearch customer in 2015 when choosing RayStation for its treatment planning. Iridium quickly appeared as an obvious choice of clinical partner to develop RayCare, the next-generation OIS, as the department spreads over seven hospitals. This, combined with a strong interest for clinical innovation, made the network a very attractive partner to develop aspects of RayCare related to coordinating cancer care efforts between institutions.

It made perfect sense to help RaySearch develop such an OIS, said Piet Dirix, radiation oncologist at Iridium.

“For me, the partnership with RaySearch was an absolute no-brainer. We needed to have an OIS that we could trust and that would help us tremendously with our workflow. Hearing that RaySearch was developing such an OIS and that they were actually looking for clinical partners to develop it with them, I became incredibly enthusiastic and we really wanted to participate in that,” he said.

Seamless Integration With RayStation

Iridium became a clinical partner to RaySearch in late 2015 and has since made a strong contribution to develop RayCare, especially with features that will support coordinated activities between different institutions. The first steps of the clinical use were done with a focus on planning workflow support and image management using RayPACS, a picture archiving and communication system (PACS) that makes it fast and easy to retrieve and share images.

“With RayCare, we can just label an image in RayPACS and then the system handles the import from RayPACS to RayStation. When launching RayStation, the patient information is there, your CT is there and you can start work directly with your patient. This is a big improvement,” Gert De Kerf, medical physics expert, said.

The tight integration between RayCare and RayStation simplifies the teamwork between clinicians, especially when different clinicians can be working on a single patient at different steps of the treatment process.

“Here at Iridium we work as a team to treat the patients. So, it is possible that I delineate a CT scan, that my colleague approves a plan, and another revises the adjustments that are made to the plan. In that way, RayCare is very crucial to the way we work,” said Carole Mercier, radiation oncologist.

“Before the implementation of RayCare we had some problems with commenting when a plan was rejected. Now, thanks to RayCare and the feedback loops, this is simplified,” De Kerf said.

The seamless integration between the systems is great, said Dirix.

“What I am most satisfied with is the close interaction with RayStation. When I push on a certain task in RayCare, RayStation immediately opens at the right patient, in the right time of his or her workflow. This really saves time,” he said.

After a few months of using the RayCare OIS they can already note some efficiency improvements. RayCare and RayStation are used together on one Linac at Iridium, which is actually the linac with the shortest waiting time within the network, according to Dirix.

“There are now around three days wait at the machine where we have RayCare and RayStation, compared to around 21 days at the other linacs. This shows you how powerful the combination is,”
Piet said.

Simplified Workflow

On top of the close interaction with RayStation, RayCare provides other valuable advantages. It has simplified the patient intake consultation process and reduced issues from 25 to 5 percent. RayCare’s schedule automation feature made it much simpler to find the optimal treatment date, eliminating the delays that could result from the complexity of the manual scheduling.

RayCare has been developed by RaySearch to meet the ends of the needs of diverse cancer centers to enable them to give the best possible care to their patients. Therefore, in RayCare digital workflows tailored to the clinic’s needs can be created. The workflows are designed to be highly configurable and tasks for specific staff members can be created automatically, triggered by defined events.

The workflows used at Iridium are custom made and set up in collaboration between Iridium and RaySearch. Six workflows for five tumor groups were specified to Iridium’s needs, with a focus on automation and optimization.

“On the stereotactic treatments we treat five different tumor groups and for these patients six workflows were created. They were all made to our specific needs; for example, we needed an anchor date for an MRI. RayCare now has an anchor date for the MRI,” said Mercier.

Comprehensive Cancer Care is the Future

Centers today often use multiple software systems, including systems for radiation oncology, medical oncology and surgical oncology. The aim with RayCare is to combine these into a single, harmonized system to manage the patient’s entire oncology treatment — from scheduling through treatment delivery and follow-up.

Iridium shares that same ultimate vision of a borderless oncology environment and the future results of the partnerships look very promising.

“I think the future of cancer care will be comprehensive. I think we have to break down the walls between radiation oncology, medical oncology, surgery and especially pathology. These need to be incorporated into a single OIS, and that is exactly what RayCare allows you to do,” said Dirix.

* Subject to regulatory clearance in some markets.

Related Content

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population. Chart courtesy of the American Cancer Society

News | Radiation Oncology | January 13, 2020
January 13, 2020 — The cancer death rate declined
Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital.

Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital. Image courtesy of Saarland University/Thorsten Mohr

 

News | Prostate Cancer | January 13, 2020
January 13, 2020 — When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewha
Lung cancer patients who are inactive prior to chemoradiation are less likely to tolerate treatment and more likely to see their cancer return
News | Lung Cancer | January 08, 2020
January 8, 2020 — Numerous ...
Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Feature | Radiation Oncology | January 03, 2020 | Dave Fornell, Editor
January 3, 2020 — Here is the top 20 pieces of radiation oncology content on the Imaging Technology News (ITN) websit
Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by an AI algorithm from RaySearch and is the subject of the No. 2 video on the list. Deep learning in radiology and radiation oncology.

Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by a machine learning algorithm from RaySearch and is the subject of the No. 2 video on the list. 

Feature | December 30, 2019
Here are the top 20 best performing videos posted on the Imaging Technology News website (ITN) from the past year, ba
Ferrotran (formerly Combidex), based on Ferumoxtran-10, is the only contrast agent which can detect lymph node metastases as small as 2 mm diameter

Ferrotran (formerly Combidex), based on Ferumoxtran-10, is the only contrast agent which can detect lymph node metastases as small as 2 mm diameter. Standard MRI or CT are not able to detect lymph node metastases smaller than 7 – 8 mm. Since most of the oncologic patients are dying due to metastases, a precise diagnostic is of utmost importance. The detection of small metastases, combined with the very clear and contrast rich MRI image of Ferrotran, enables an earlier and more precise treatment. Therefore, Ferrotran gives the patient a much higher chance of recovery.

News | Prostate Cancer | December 24, 2019
December 24, 2019 — SPL Medical announced today that the first patient has been successfully diagnosed with suspected
Beamscan MR for ViewRay MRIdian and for Elekta Unity

Beamscan MR for ViewRay MRIdian and for Elekta Unity

News | Radiation Therapy | December 23, 2019
December 23, 2019 — The Beamscan MR motorized 3-D...
radiation exposure triggers an immune response in the brain that severs connections between nerve cells
News | Clinical Trials | December 17, 2019
December 17, 2019 — One of the potentially life-altering side effects that patients experience after...